z-logo
Premium
Early experience with the use of hepatitis C antibody‐positive, nucleic acid testing‐negative donors in lung transplantation
Author(s) -
Watson Joshua,
Mulvihill Michael S.,
Cox Morgan L.,
Rich Lauren,
Wolfe Cameron R.,
Gray Alice,
Hartwig Matthew G.
Publication year - 2019
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13476
Subject(s) - medicine , nucleic acid , lung transplantation , transplantation , antibody , liver transplantation , donor specific antibodies , lung , hepatitis c , immunology , nucleic acid test , virology , covid-19 , kidney transplantation , disease , biochemistry , infectious disease (medical specialty) , chemistry
Historically, potential lung donors who have detectable antibodies to hepatitis C virus have been declined by most centers due to concern for possible disease transmission. We sought to evaluate hepatitis C viral transmission rates from donors who were known to be HCV Ab positive but HCV NAT negative. We performed a single‐center retrospective review of a prospectively collected database for lung transplant recipients at our center including HCV Ab+NAT‐ donors (approved January 2017). Donor and recipient demographic data were compiled, and records were queried to ascertain rate of seroconversion. During the study period (1/1/17 to 8/9/17), a total of 64 recipients underwent lung transplantation. Thirteen (20%) donors were HCV Ab+NAT‐. All recipients of HCV Ab+NAT‐ grafts were HCV Ab‐ at the time of transplant. Recipients of grafts from HCV Ab+NAT‐ donors underwent protocol NAT at 2 and 12 months and all are NAT‐ to date. One recipient developed reactive HCV Ab at 6 months post‐transplant. Follow‐up NAT showed HCV RNA to be undetectable. To date, use of HCV Ab+NAT‐ donors in lung transplantation has yielded favorable outcomes, with evidence of one transient seroconversion suggesting this practice may increase access to life‐saving transplantation to those in need.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here